CEFADROXIL (CEFADROXIL/CEFADROXIL HEMIHYDRATE) — FDA Approval ANDA205072 (CSPC OUYI)
CEFADROXIL (CEFADROXIL/CEFADROXIL HEMIHYDRATE) — FDA Approval ANDA205072 (CSPC OUYI) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFADROXIL; Active ingredients: CEFADROXIL/CEFADROXIL HEMIHYDRATE; Application number: ANDA205072.
| Brand name | CEFADROXIL |
|---|---|
| Active ingredients | CEFADROXIL/CEFADROXIL HEMIHYDRATE |
| Application number | ANDA205072 |
| Sponsor | CSPC OUYI |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20170728 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →